- Home
- GCMG vs ABSI Comparison
GCMG vs ABSI Comparison
Compare GCMG & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMG
- ABSI
- Stock Information
- Founded
- GCMG 1971
- ABSI 2011
- Country
- GCMG United States
- ABSI United States
- Employees
- GCMG N/A
- ABSI N/A
- Industry
- GCMG Finance/Investors Services
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- GCMG Finance
- ABSI Health Care
- Exchange
- GCMG Nasdaq
- ABSI Nasdaq
- Market Cap
- GCMG 631.4M
- ABSI 505.4M
- IPO Year
- GCMG N/A
- ABSI 2021
- Fundamental
- Price
- GCMG $11.73
- ABSI $3.71
- Analyst Decision
- GCMG Buy
- ABSI Strong Buy
- Analyst Count
- GCMG 4
- ABSI 6
- Target Price
- GCMG $15.13
- ABSI $7.98
- AVG Volume (30 Days)
- GCMG 706.9K
- ABSI 6.2M
- Earning Date
- GCMG 11-07-2025
- ABSI 11-11-2025
- Dividend Yield
- GCMG 3.74%
- ABSI N/A
- EPS Growth
- GCMG N/A
- ABSI N/A
- EPS
- GCMG 0.19
- ABSI N/A
- Revenue
- GCMG $533,097,999.00
- ABSI $4,138,000.00
- Revenue This Year
- GCMG $4.88
- ABSI $41.73
- Revenue Next Year
- GCMG $11.78
- ABSI $384.22
- P/E Ratio
- GCMG $63.32
- ABSI N/A
- Revenue Growth
- GCMG 15.56
- ABSI 27.32
- 52 Week Low
- GCMG $10.91
- ABSI $2.01
- 52 Week High
- GCMG $14.48
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- GCMG 32.59
- ABSI 68.91
- Support Level
- GCMG $11.67
- ABSI $2.48
- Resistance Level
- GCMG $12.03
- ABSI $3.70
- Average True Range (ATR)
- GCMG 0.26
- ABSI 0.24
- MACD
- GCMG -0.11
- ABSI 0.12
- Stochastic Oscillator
- GCMG 4.82
- ABSI 81.85
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.